Publisher’s Note: New Survey Aimed at PH Patients Not Currently on Treatment
Based on recently conducted surveys, we know there is a subset of patients with pulmonary hypertension who are currently not on therapies approved by the U.S. Food and Drug Administration to treat their pulmonary hypertension.
There is a wide range of possible reasons. These PH patients may either choose not to take disease-modifying therapies or their doctors may not have prescribed them yet.
Pulmonary Hypertension News hopes to learn what drives these decisions so that we can do a better job of meeting the informational needs of our readers who still manage their PH without these treatments.
Our newest survey seeks to better understand the contributing factors that lead to PH patients not taking any treatments. Please take a few minutes to respond to our short survey. As always, we look forward to serving the PH patient population and offering new perspectives and information on how patients are living life to the fullest despite this disease.